These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. D1 dopamine receptor signalling defect in spontaneous hypertension. Felder RA; Eisner GM; Jose PA Acta Physiol Scand; 2000 Jan; 168(1):245-50. PubMed ID: 10691808 [TBL] [Abstract][Full Text] [Related]
6. The renal dopamine receptors. Jose PA; Raymond JR; Bates MD; Aperia A; Felder RA; Carey RM J Am Soc Nephrol; 1992 Feb; 2(8):1265-78. PubMed ID: 1627751 [TBL] [Abstract][Full Text] [Related]
7. Role of dopamine in the pathogenesis of hypertension. Jose PA; Eisner GM; Felder RA Clin Exp Pharmacol Physiol Suppl; 1999 Apr; 26():S10-3. PubMed ID: 10386248 [TBL] [Abstract][Full Text] [Related]
8. [Recent findings regarding physiological characteristics and effects of renal dopamine]. Cuk M; Cuk D; Dvornik S; Mamula O; Manestar MM Lijec Vjesn; 2004; 126(5-6):147-55. PubMed ID: 15628684 [TBL] [Abstract][Full Text] [Related]
9. Dopamine receptor signaling defects in spontaneous hypertension. Jose PA; Eisner GM; Drago J; Carey RM; Felder RA Am J Hypertens; 1996 Apr; 9(4 Pt 1):400-5. PubMed ID: 8722444 [TBL] [Abstract][Full Text] [Related]
12. Dopamine and vascular dynamics control: present status and future perspectives. Tayebati SK; Lokhandwala MF; Amenta F Curr Neurovasc Res; 2011 Aug; 8(3):246-57. PubMed ID: 21722093 [TBL] [Abstract][Full Text] [Related]
13. Renal dopaminergic mechanisms and hypertension: a chronology of advances. O'Connell DP; Aherne AM Clin Exp Hypertens; 2000 Apr; 22(3):217-49. PubMed ID: 10803730 [TBL] [Abstract][Full Text] [Related]
14. Dopamine and renal function and blood pressure regulation. Armando I; Villar VA; Jose PA Compr Physiol; 2011 Jul; 1(3):1075-117. PubMed ID: 23733636 [TBL] [Abstract][Full Text] [Related]
15. Regulation of blood pressure by dopamine receptors. Jose PA; Eisner GM; Felder RA Nephron Physiol; 2003; 95(2):p19-27. PubMed ID: 14610323 [TBL] [Abstract][Full Text] [Related]
16. What we can learn from the selective manipulation of dopaminergic receptors about the pathogenesis and treatment of hypertension? Jose PA; Felder RA Curr Opin Nephrol Hypertens; 1996 Sep; 5(5):447-51. PubMed ID: 8937815 [TBL] [Abstract][Full Text] [Related]
17. The dopaminergic system in hypertension. Zeng C; Zhang M; Asico LD; Eisner GM; Jose PA Clin Sci (Lond); 2007 Jun; 112(12):583-97. PubMed ID: 17492945 [TBL] [Abstract][Full Text] [Related]
18. Studying the dopaminergic system with transfected receptors. Yamaguchi I; Walk SF; Felder RA Hypertens Res; 1995 Jun; 18 Suppl 1():S19-22. PubMed ID: 8529058 [TBL] [Abstract][Full Text] [Related]
19. Dopamine receptors: from structure to function. Missale C; Nash SR; Robinson SW; Jaber M; Caron MG Physiol Rev; 1998 Jan; 78(1):189-225. PubMed ID: 9457173 [TBL] [Abstract][Full Text] [Related]
20. The dopamine receptor in adult and maturing kidney. Felder RA; Felder CC; Eisner GM; Jose PA Am J Physiol; 1989 Sep; 257(3 Pt 2):F315-27. PubMed ID: 2571302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]